Autres langues Cytogen, Inc.

Actions

A217330

KR7217330000

Cours en clôture Korea S.E. Autres places de cotation 00:00:00 09/05/2024			Varia. 5j.	Varia. 1 janv.
11 250 ^KRW	-1,23 %		-2,93 %	-16,79 %

2023

Cytogen, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2022

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Cytogen, Inc. announced that it has received KRW 9.8 billion in funding from NH Investment & Securities Co., Ltd., Samsung Securities Co., Ltd. and other investors	20/03
Cytogen, Inc. announced that it expects to receive KRW 9.8 billion in funding from NH Investment & Securities Co., Ltd., Samsung Securities Co., Ltd. and other investors	18/03
Cytogen, Inc. announced that it has received KRW 55.49999 billion in funding from CanDx Holdings Limited	28/12
Cytogen, Inc. announced that it expects to receive KRW 99.999821616 billion in funding from Candx Holdings Limited	28/12
Candx Holdings Limited agreed to acquire a 31.96% stake in Cytogen, Inc. from Jeon Byung Hee and others for KRW 110 billion	19/12
Cytogen, Inc. announces tranche update	27/10/23
Cytogen Raising KRW10 Billion to Finance Operations	27/09/23
Cytogen, Inc. announced that it expects to receive KRW 69.99999 billion in funding from Excelsior Capital Korea Limited	26/09/23
Cytogen, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	17/03/23
Cytogen, Inc.(KOSDAQ:A217330) added to S&P Global BMI Index	20/09/21
TSD Life Sciences Co.,Ltd. announced that it has received KRW 2.9999853 billion in funding from Cytogen, Inc.	21/05/21
TSD Life Sciences Co.,Ltd. announced that it has received KRW 2.9999853 billion in funding from Cytogen, Inc.	21/05/21
Cytogen, Inc. announced that it has received KRW 30 billion in funding	20/05/21
Cytogen, Inc. announced that it expects to receive KRW 30 billion in funding	17/05/21
TSD Life Sciences Co.,Ltd. announced that it expects to receive KRW 2.9999853 billion in funding from Cytogen, Inc.	17/05/21
Cytogen, Inc. announced that it has received KRW 10 billion in funding	25/09/20
Cytogen, Inc. announced that it expects to receive KRW 10 billion in funding	04/09/20
Well Marker Bio Co., Ltd. announced that it has received KRW 18 billion in funding from a group of investors	08/07/19
Cytogen, Inc. has completed an IPO in the amount of KRW 20.4 billion.	21/11/18
Cytogen, Inc. has filed an IPO.	20/02/18

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Cytogen, Inc.

Actions

A217330

KR7217330000

Autres langues

Filtres